Abacavir sulphate

Abacavir sulphate
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abacavir sulphate. It belongs to antiretroviral apis category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone

    Product 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.
  • 4-methylsulphonylbenzyl-3-(6-methyl)-pyridyl ketone

    Product 4-methylsulphonylbenzyl-3-(6-methyl)-pyridyl ketone

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-methylsulphonylbenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.
  • 6-chloro-4-hydroxy-2-methyl-3-methoxycarbonyl-2h-thieno-[2,3-e]-1

    Product 6-chloro-4-hydroxy-2-methyl-3-methoxycarbonyl-2h-thieno-[2,3-e]-1

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-chloro-4-hydroxy-2-methyl-3-methoxycarbonyl-2h-thieno-[2,3-e]-1. It belongs to lornoxicam intermediates products category. Contact us for more information.
  • 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]

    Product 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4 ?dihydro-2h-1-benzopyran -2-carboxylic acid [99199-60-7]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.
  • 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]

    Product 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 6-fluoro-3,4-dihydro-2-oxyranyl-2h-1-benzopyran [99199-90-3]. It belongs to nebivolol hydrochloride intermediates products category. Contact us for more information.
  • 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]

    Product 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 7-(3-(aminomethyl)-4-(methoxyimino)-pyrrodin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]. It belongs to gemifloxacin intermediates products category. Contact us for more inf...
  • Abiraterone

    Product Abiraterone

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes abiraterone. It belongs to anticancer apis category. Contact us for more information.
  • Aceclofenac

    Product Aceclofenac

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac. It belongs to antiinflammatory ( nsaid ) apis category. Contact us for more information.
  • Aceclofenac injections 150 mg

    Product Aceclofenac injections 150 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac injections 150 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.
  • Aceclofenac sustained release tablets 200 mg

    Product Aceclofenac sustained release tablets 200 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac sustained release tablets 200 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.
  • Aceclofenac tablets 100 mg

    Product Aceclofenac tablets 100 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac tablets 100 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.
  • Acyclovir

    Product Acyclovir

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes acyclovir. It belongs to lypholised powder ready to fill category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)